Pharmacy news and alerts

This page provides pharmacy-related safety alerts, drug recall and new generic drug announcements and other medication information.

Drug recall notice for Auvi-Q epinephrine injections

We want to alert you to a recall of Auvi-Q epinephrine injections, effective Oct. 26, 2015.

Sanofi US voluntarily recalled all Auvi-Q currently on the market, including the 0.15 mg and 0.3 mg strengths. This recall was initiated due to reports of possible device malfunctions that could result in inaccurate dosage delivery or failure to deliver the drug.

Auvi‑Q is packaged with two active devices and one trainer device in a corrugated box.

The recall includes the NDC and lot numbers in the table below.

NDC Product Lot Expiration Configuration/Count



Auvi‑Q 2081278 through 3037230 October 2015 through December 2016 Dosage delivery

Humana is notifying members who had pharmacy claims for Auvi-Q in the last 365 days about this drug recall.

Customers who received the affected product should immediately contact their physician to request a prescription for an alternate epinephrine auto-injector. In the event of a life- threatening allergic reaction (anaphylaxis), members should only use their Auvi-Q device if another epinephrine auto-injector is not available, and then they should call 911.

For more information, contact Sanofi US at 1-877-319-8963 or 1-866-726-6340. Representatives are available Monday through Friday from 8 a.m. to 8 p.m. Eastern time.